Natrix raises $19 million for commercialization

Burlington ON-based Natrix Separations Inc has closed a $19-million, series B financing to support commercialization of its separation products and complete construction of its ISO9001-compliant manufacturing facility. DE Shaw Venture Capital, Cupertino CA, is the lead investors with participation by BDC Venture Capital and Canadian Medical Discovery Funds (now part of Jovian Capital Corp). The privately held company has developed its patented Adsept technology which can be used to capture specific target molecules from a broad range of feed streams. Its membrane-based chromatography applications are used to purify therapeutic drugs, produce nutraceuticals from commodity food products and remove heavy metals from drinking water. It is targeting the life science, bioprocessing , nutraceutical, food, beverage and potable water/wastewater markets….